Glomerular and immune-mediated kidney diseases represent a diverse group of conditions in which the kidney’s filtering units (glomeruli) are damaged by immune mechanisms. These disorders can lead to proteinuria, hematuria, hypertension, and progressive loss of kidney function if not diagnosed and treated early.

At IMH, management of glomerular diseases is led by experienced nephrologists using a structured, evidence-based approach that integrates precision diagnostics, immunomodulatory therapy, and long-term monitoring.

Common conditions include various forms of glomerulonephritis, nephrotic syndrome, IgA nephropathy, membranous nephropathy, and vasculitis-related kidney involvement. Diagnosis often requires a combination of laboratory tests, imaging, and kidney biopsy to determine disease subtype and activity.

Treatment strategies are individualized based on disease severity, pathology findings, and patient comorbidities. Supportive therapy includes blood pressure control, proteinuria reduction, and kidney-protective measures. When indicated, immunosuppressive therapies are introduced under close supervision.

By combining advanced diagnostics with personalized therapy, IMH delivers effective management of immune-mediated kidney diseases while preserving kidney function and improving long-term outcomes.